Source link : https://newshealth.biz/health-news/overall-survival-win-for-osimertinib-chemotherapy-in-first-line-egfr-mutated-nsclc/
(MedPage Today) — First-line osimertinib (Tagrisso) plus chemotherapy significantly improved survival versus osimertinib monotherapy in patients with EGFR-mutated advanced non-small cell lung cancer (NSCLC). Among a total of 557 patients, and… Source link : https://www.medpagetoday.com/meetingcoverage/iaslc/117347 Author : Publish date : 2025-09-08 00:32:00 Copyright for syndicated content belongs to the linked Source.
The post Overall Survival Win for Osimertinib-Chemotherapy in First-Line EGFR-Mutated NSCLC first appeared on News Health.
—-
Author : News Health
Publish date : 2025-09-08 00:32:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8